98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283421 | PMC |
http://dx.doi.org/10.1016/j.hrcr.2021.03.023 | DOI Listing |
Cureus
September 2025
Cardiology, KAAJ Healthcare, San Jose, USA.
We present the case of an 88-year-old female who presented to the cardiologist's clinic with symptoms of palpitations, dizziness, and fatigue. After cardiac monitoring, the patient was diagnosed with symptomatic bradycardia and required a pacemaker. During the pacemaker implantation procedure, attempts to access the subclavian vein were unsuccessful, and venography revealed severe venous spasm.
View Article and Find Full Text PDFHeartRhythm Case Rep
August 2025
Heart Rhythm Center, Department of Cardiovascular Medicine, Sendai Kosei Hospital, Miyagi, Japan.
Front Cardiovasc Med
August 2025
Department of Radiation Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Metastatic melanomas with prolonged survival are becoming increasingly common. We present the case of a 47-year-old man with melanoma who developed asymptomatic cardiac metastases, whose prognosis depended on their response to either systemic or focal treatment. Consequently, a CyberKnife radiotherapy treatment was performed using a pacemaker for tracking.
View Article and Find Full Text PDFRev Esp Cardiol (Engl Ed)
August 2025
Servicio de Cardiología, Instituto Cardiovascular del Hospital Clínico San Carlos, Fundación para la Investigación Biomédica del Hospital Clínico San Carlos (IDISCC), Madrid, España; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carl
Introduction: This report presents data on cardiac pacing system implants in Spain during 2024.
Methods: The registry is based on data voluntarily submitted by implanting centers to the Heart Rhythm Association of the Spanish Society of Cardiology via the national online platform, CardioDispositivos. Additional data sources included: a) data provided by device manufacturers and distributors, b) the European pacemaker patient card, and c) local databases submitted by implanting centers.
Biomedicines
August 2025
Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
: Patients with end-stage renal disease (ESRD) are at elevated risk for device-related complications following pacemaker implantation. Leadless pacemakers (LPMs) offer theoretical advantages over transvenous pacemakers (TVPs), but their safety and efficacy in this high-risk population remain unclear. Our aim was to compare clinical outcomes and complication profiles between leadless and transvenous pacemakers in patients with ESRD.
View Article and Find Full Text PDF